Skip to main content
. Author manuscript; available in PMC: 2014 Jan 1.
Published in final edited form as: Am J Med. 2013 Jan;126(1):74.e11–74.e17. doi: 10.1016/j.amjmed.2012.07.005

Figure 3.

Figure 3

Study completion among opioid-dependent patients receiving buprenorphine/naloxone in primary care. Study completion was defined as not meeting the criteria for protective transfer, not missing medication for more than 7 days, or not missing 3 or more physician management sessions.